REG - Adv Medical Solutns. - Director/PDMR Shareholding
RNS Number : 2266WAdvanced Medical Solutions Grp PLC21 April 2021
21 April 2021
Advanced Medical Solutions Group plc
("AMS", the "Company" or the "Group")
Director/PDMR Shareholding
Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the surgical and advanced wound care specialist company, announces that on 16 April 2021, the Board, following a recommendation from the Remuneration Committee, granted new share options to the following Directors/PDMRs under the existing Advanced Medical Solutions Long Term Incentive Plan (the 'LTIP'). The vesting of these options is based on achieving certain performance criteria for the three years prior to vesting. The performance criteria under the LTIP scheme is split equally between Earnings Per Share (EPS) growth against fixed targets and Total Shareholder Return (TSR) against a comparator group. The performance criteria have remained unchanged for the last seven years.
Director/PDMR
Options prior to grant
Options granted
Resultant LTIP holdings
Chris Meredith
Chief Executive Officer
884,329
238,963
1,123,292
Eddie Johnson
Chief Financial Officer
210,323
67,706
278,029
The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1.
Details of the person discharging managerial responsibilities/person closely associated
a)
Name: Chris Meredith
2.
Reason for the notification
a)
Position/status: Director/PDMR
b)
Initial notification/Amendment: Initial Notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name: Advanced Medical Solutions Group plc
b)
LEI: 213800HJP6OWOSZI1L74
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument: Ordinary Shares of 5p
Identification code: GB0004536594
b)
Nature of the transactions:
· Grant of 238,963 options under the Advanced Medical Solutions Long Term Incentive Plan on 16 April 2021
c)
Price(s) and volume(s):
Price(s)
Volume(s)
Nil-cost
238,963
d)
Aggregated information:
Aggregated volume: n/a
Aggregated price: n/a
e)
Date of the transaction: 16/04/2021
f)
Place of the transaction: London Stock Exchange, AIM Market (XLON)
1.
Details of the person discharging managerial responsibilities/person closely associated
a)
Name: Eddie Johnson
2.
Reason for the notification
a)
Position/status: Director/PDMR
b)
Initial notification/Amendment: Initial Notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name: Advanced Medical Solutions Group plc
b)
LEI: 213800HJP6OWOSZI1L74
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument: Ordinary Shares of 5p
Identification code: GB0004536594
b)
Nature of the transactions:
· Grant of 67,706 options under the Advanced Medical Solutions Long Term Incentive Plan on 16 April 2021
c)
Price(s) and volume(s):
Price(s)
Volume(s)
Nil-cost
67,706
d)
Aggregated information:
Aggregated volume: n/a
Aggregated price: n/a
e)
Date of the transaction: 16/04/2021
f)
Place of the transaction: London Stock Exchange, AIM Market (XLON)
-End -
For further information, please visit www.admedsol.com or contact:
Advanced Medical Solutions Group plc
Tel: +44 (0) 1606 545508
Chris Meredith, Chief Executive Officer
Eddie Johnson, Chief Financial Officer
Consilium Strategic Communications
Tel: +44 (0) 20 3709 5700
Mary-Jane Elliott / Matthew Neal / Olivia Manser
AMS@consilium-comms.com
Investec Bank PLC (NOMAD & Broker)
Tel: +44 (0) 20 7597 5970
Daniel Adams / Gary Clarence / Patrick Robb
About Advanced Medical Solutions Group plc
AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical and woundcare markets, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, and internal fixation devices, which it markets under its brands LiquiBand®, RESORBA®, and LiquiBandFix8®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal® brand as well as under white label. In 2019, the Group made two acquisitions: Sealantis, an Israeli medical device company with a patent-protected sealant technology platform; and Biomatlante, an established developer and manufacturer of innovative surgical biomaterial technologies based in France. In 2020, the Group acquired Raleigh Adhesive Coatings, a leading coater and converter of materials predominately for woundcare and bio-diagnostics products based in the UK.
AMS's products, manufactured in the UK, Germany, France, the Netherlands, and the Czech Republic, are sold globally via a network of multinational or regional partners and distributors, as well as via AMS's own direct sales forces in the UK, Germany, the Czech Republic and Russia. The Group has R&D innovation hubs in the UK, Germany, France and Israel. Established in 1991, the Group has approximately 700 employees. For more information, please see www.admedsol.com.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDDSHBRGDSIBDDGBB
Recent news on Advanced Medical Solutions
See all newsREG - Adv Medical Solutns. - Annual Report and Notice of Annual General Meeting
AnnouncementREG - Adv Medical Solutns. - Total Voting Rights
AnnouncementREG - Adv Medical Solutns. - Director/PDMR Shareholding
AnnouncementREG - Adv Medical Solutns. - Holding(s) in Company
AnnouncementREG - Adv Medical Solutns. - Holding(s) in Company
Announcement